Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from MedAdvisor Limited ( (AU:MDR) ) is now available.
MedAdvisor Limited announced a change in the director’s interest notice, with Director Lucas Merrow acquiring 500,000 fully paid ordinary shares, increasing his total holdings to 1,440,290 shares. This acquisition was part of a placement of shares approved by shareholders, reflecting confidence in the company’s strategic direction and potentially impacting investor perceptions positively.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare technology industry, focusing on digital medication management solutions. The company provides platforms and services that help patients manage their medications effectively, aiming to improve health outcomes and streamline communication between patients and healthcare providers.
Average Trading Volume: 879,399
Technical Sentiment Signal: Sell
Current Market Cap: A$16.45M
Learn more about MDR stock on TipRanks’ Stock Analysis page.